Controlled Continuous Evolution of Enzymatic Activity Screened at Ultrahigh Throughput Using Drop‐Based Microfluidics

Author:

Rosenthal R. G.12,Diana Zhang X.1,Đurđić K. Ilić134ORCID,Collins J. J.23567,Weitz D. A.138ORCID

Affiliation:

1. School of Engineering and Applied Sciences Harvard University Cambridge MA 02138 USA

2. Institute for Medical Engineering and Science Massachusetts Institute of Technology 77 Massachusetts Ave Cambridge MA 02139 USA

3. Wyss Institute for Biologically Inspired Engineering Harvard University 3 Blackfan Circle Boston MA 02115 USA

4. University of Belgrade-Faculty of Chemistry Studentski trg 12–16 11000 Belgrade Serbia

5. Department of Biological Engineering Massachusetts Institute of Technology 77 Massachusetts Ave Cambridge MA 02139 USA

6. Synthetic Biology Center Massachusetts Institute of Technology 77 Massachusetts Ave Cambridge MA 02139 USA

7. Harvard-MIT Program in Health Sciences and Technology Massachusetts Institute of Technology 77 Massachusetts Ave Cambridge MA 02139 USA

8. Department of Physics Harvard University Cambridge MA 02138 USA

Abstract

AbstractEnzymes are highly specific catalysts delivering improved drugs and greener industrial processes. Naturally occurring enzymes must typically be optimized which is often accomplished through directed evolution; however, this is still a labor‐ and capital‐intensive process, due in part to multiple molecular biology steps including DNA extraction, in vitro library generation, transformation, and limited screening throughput. We present an effective and broadly applicable continuous evolution platform that enables controlled exploration of fitness landscape to evolve enzymes at ultrahigh throughput based on direct measurement of enzymatic activity. This drop‐based microfluidics platform cycles cells between growth and mutagenesis followed by screening with minimal human intervention, relying on the nCas9 chimera with mutagenesis polymerase to produce in vivo gene diversification using sgRNAs tiled along the gene. We evolve alditol oxidase to change its substrate specificity towards glycerol, turning a waste product into a valuable feedstock. We identify a variant with a 10.5‐fold catalytic efficiency.

Funder

National Science Foundation

European Molecular Biology Organization

Materials Research Science and Engineering Center, Harvard University

Publisher

Wiley

Subject

General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3